January 3 Deadline Alert: Law Offices of Howard G. Smith Reminds Allergan PLC Investors of Upcoming Lead Plaintiff Deadline &...
29 December 2016 - 7:42AM
Business Wire
Law Offices of Howard G. Smith reminds investors of the
upcoming January 3, 2017 deadline to file a lead
plaintiff motion in the class action filed on behalf of investors
who purchased Allergan PLC (“Allergan” or the “Company”) (NYSE:
AGN) securities between February 25, 2014 and November 3,
2016, inclusive (the “Class Period”). Allergan investors have
until January 3, 2017 to file a lead plaintiff
motion.
According to the Complaint filed in this lawsuit, Allergan made
false and/or misleading statements and/or failed to disclose that:
the Company and Actavis (an Allergan subsidiary) engaged in conduct
that would result in a Department of Justice (“DOJ”) antitrust
investigation; that the DOJ investigation and the underlying
conduct could cause U.S. prosecutors to file criminal charges
against the Company by the end of 2016 for suspected price
collusion; that Allergan and Actavis lacked effective internal
controls; and that as a result of the above, Allergan’s and
Actavis’ public statements were materially false and misleading at
all relevant times.
Note: On December 14, 2016, the United States Justice Department
accused two executives of colluding with other generic
pharmaceutical companies to fix prices, the first criminal charges
stemming from a sweeping criminal investigation into alleged price
fixing by over a dozen generic drug companies.
If you purchased Allergan shares, you may move the Court no
later than January 3, 2017 to request appointment
as lead plaintiff. To be a member of the class you need not take
any action at this time; you may retain counsel of your choice or
take no action and remain an absent member of the Class. If you
wish to learn more about this action, or if you have any
questions concerning this announcement or your rights or interests
with respect to these matters, please contact Howard G. Smith,
Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike,
Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website
at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161228005408/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2024 to May 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From May 2023 to May 2024